{
    "2020-02-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Pfizer's Xtandi Improves OS Rate in Prostate Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xtandi",
                        "OS Rate",
                        "Prostate Cancer",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Buy AbbVie for its Growth Prospects, Yield and Low Valuation",
                "features": {
                    "keywords": [
                        "Buy",
                        "AbbVie",
                        "Growth Prospects",
                        "Yield",
                        "Low Valuation"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}